Skip to main content Back to Top
Advertisement

11/13/2019

Ceftriaxone Sodium Injection

Products Affected - Description

    • Ceftriaxone injection, Lupin, 1 gram, vial, 10 count, NDC 68180-0633-10 - discontinued
    • Ceftriaxone injection, Lupin, 2 gram, vial, 10 count, NDC 68180-0644-10 - discontinued
    • Ceftriaxone injection, Lupin, 250 mg, vial, 10 count, NDC 68180-0611-10 - discontinued
    • Ceftriaxone injection, Lupin, 500 mg, vial, 10 count, NDC 68180-0622-10 - discontinued

Reason for the Shortage

    • Apotex has ceftriaxone available.
    • Fresenius Kabi states the reason for the shortage was increased demand.
    • Hikma states the reason for the shortage was manufacturing delay.
    • Lupin has discontinued their ceftriaxone presentations.
    • Pfizer had ceftriaxone injection on shortage due to increased demand and manufacturing delays.
    • Piramal Critical Care has ceftriaxone injection available.
    • Sagent has ceftriaxone available.
    • Sandoz did not provide a reason for the shortage.
    • Wockhardt has discontinued their ceftriaxone presentations.

Available Products

    • Ceftriaxone injection, Apotex, 1 gram, vial, 10 count, NDC 60505-6148-04
    • Ceftriaxone injection, Apotex, 10 gram, vial, 1 count, NDC 60505-6150-05
    • Ceftriaxone injection, Apotex, 2 gram, vial, 10 count, NDC 60505-6149-04
    • Ceftriaxone injection, Apotex, 250 mg, vial, 1 count, NDC 60505-6151-04
    • Ceftriaxone injection, Apotex, 250 mg, vial, 10 count, NDC 60505-6151-01
    • Ceftriaxone injection, Apotex, 500 mg, vial, 1 count, NDC 60505-6152-04
    • Ceftriaxone injection, Apotex, 500 mg, vial, 10 count, NDC 60505-6152-01
    • Ceftriaxone injection, BBraun, 1 gram/50 mL, premixed bag, 24 count, NDC 00264-3153-11
    • Ceftriaxone injection, BBraun, 2 gram/50 mL, premixed bag, 24 count, NDC 00264-3155-11
    • Ceftriaxone injection, Baxter, 1 gram/50 mL, premixed bag, 24 count, NDC 00338-5002-41
    • Ceftriaxone injection, Baxter, 2 gram/50 mL, premixed bag, 24 count, NDC 00338-5003-41
    • Ceftriaxone injection, Fresenius Kabi, 1 gram, vial, 25 count, NDC 63323-0346-10
    • Ceftriaxone injection, Fresenius Kabi, 10 gram, vial, 1 count, NDC 63323-0348-61
    • Ceftriaxone injection, Fresenius Kabi, 2 gram, vial, 10 count, NDC 63323-0347-20
    • Ceftriaxone injection, Fresenius Kabi, 250 mg, vial, 25 count, NDC 63323-0344-10
    • Ceftriaxone injection, Fresenius Kabi, 500 mg, vial, 25 count, NDC 63323-0345-10
    • Ceftriaxone injection, Hikma, 1 gram, vial, 25 count, NDC 00143-9857-25
    • Ceftriaxone injection, Hikma, 2 gram, vial, 25 count, NDC 00143-9856-25
    • Ceftriaxone injection, Hikma, 250 mg, vial, 25 count, NDC 00143-9859-25
    • Ceftriaxone injection, Hikma, 500 mg, vial, 25 count, NDC 00143-9858-25
    • Ceftriaxone injection, Pfizer, 1 gram, ADD-Vantage vial, 10 count, NDC 00409-7333-04
    • Ceftriaxone injection, Pfizer, 1 gram, vial, 10 count, NDC 00409-7332-01
    • Ceftriaxone injection, Pfizer, 10 gram, vial, 1 count, NDC 00409-7334-10
    • Ceftriaxone injection, Pfizer, 2 gram, ADD-Vantage vial, 10 count, NDC 00409-7336-04
    • Ceftriaxone injection, Pfizer, 2 gram, vial, 10 count, NDC 00409-7335-03
    • Ceftriaxone injection, Pfizer, 250 mg, vial, 10 count, NDC 00409-7337-01
    • Ceftriaxone injection, Pfizer, 500 mg, vial, 10 count, NDC 00409-7338-01
    • Ceftriaxone injection, Piramal Critical Care, 1 gram, vial, 25 count, NDC 66794-0213-42
    • Ceftriaxone injection, Piramal Critical Care, 2 gram, vial, 25 count, NDC 66794-0214-42
    • Ceftriaxone injection, Piramal Critical Care, 250 mg, vial, 25 count, NDC 66794-0211-42
    • Ceftriaxone injection, Piramal Critical Care, 500 mg, vial, 25 count, NDC 66794-0212-42
    • Ceftriaxone injection, Sagent, 1 gram, vial, 25 count, NDC 25021-0106-10
    • Ceftriaxone injection, Sagent, 10 gram, vial, 1 count, NDC 25021-0108-99
    • Ceftriaxone injection, Sagent, 2 gram, vial, 25 count, NDC 25021-0107-20
    • Ceftriaxone injection, Sagent, 500 mg, vial, 25 count, NDC 25021-0105-10
    • Ceftriaxone injection, Samson Medical Technologies, 100 gram, SmartPak bulk vial, 1 count, NDC 66288-6100-01
    • Ceftriaxone injection, Sandoz, 1 gram, vial, 10 count, NDC 00781-3208-95
    • Ceftriaxone injection, Sandoz, 10 gram, vial, 1 count, NDC 00781-3210-46
    • Ceftriaxone injection, Sandoz, 2 gram, vial, 10 count, NDC 00781-3209-95
    • Ceftriaxone injection, Sandoz, 250 mg, vial, 10 count, NDC 00781-3206-95
    • Ceftriaxone injection, Sandoz, 500 mg, vial, 10 count, NDC 00781-3207-95
    • Ceftriaxone injection, WG Critical Care, 1 gram, vial, 25 count, NDC 44567-0701-25
    • Ceftriaxone injection, WG Critical Care, 10 gram, vial, 1 count, NDC 44567-0703-01
    • Ceftriaxone injection, WG Critical Care, 2 gram, vial, 25 count, NDC 44567-0702-25

Updated

Updated November 13, 2019 by Megan Dryer, PharmD. Created May 1, 2014 by Jane Chandramouli, PharmD, Drug Information Specialist. © 2019, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

Drug Shortage Bulletins are copyrighted by the Drug Information Service of the University of Utah and provided by ASHP as its exclusive authorized distributor. ASHP and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, with respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this Bulletin. Neither ASHP nor the University of Utah endorses or recommends the use of any particular drug. Any application of this information for any purpose shall be limited to personal, non-commercial use.

« Back to Drug Shortage Product Bulletins


ahfs logo

Subscribe to AHFS Clinical Drug Information to get direct access to integrated drug shortages content, plus comprehensive and actionable drug information.
ADVERTISEMENT